Stig Hansen, Carmot Therapeutics co-founder and CEO
July 26, 2022 10:31 AM EDT
Financing

RA Cap­i­tal jumps on board di­a­betes biotech, pitch­ing in on $160M Se­ries D

Paul Schloesser

Associate Editor

A small Cal­i­for­nia biotech is back with more cash and a new big name VC to work with.

Car­mot Ther­a­peu­tics re­port­ed a Se­ries D fi­nanc­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times